Now showing items 1-1 of 1
Fernández Martínez, Aranzazu (Date of defense: 2021-07-16)
[eng] HR-positive/HER2-negative (HR+/HER2-) is the most common breast cancer type, and it is a molecular heterogenic disease. This heterogeneity has direct prognostic and predictive implications in both early and advanced ...